Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Voiding position - Standing in the shower, Voiding position - Sitting on the toilet.
- Who it may be relevant to
- Registry conditions: Post-void Residual Volume, Recatheterization, Pain, UTI. Basic parameters: 18 years — 99 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Israel
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery: A Double-Blind Randomized Controlled Trial
Overview
The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.
Interventions
- Behavioral Voiding position - Standing in the shower
After the removal of urine catheter, for the first micturation the woman will stand in the shower with the water on her vulvar area - Behavioral Voiding position - Sitting on the toilet
After the removal of urine catheter, for the first micturation the women will sit on the toiled
Primary outcome measures
- Post-void residual volume>150 CC [Time frame: The following 7 days after surgery]
Secondary outcome measures (5)
- Success rate of voiding trial [Time frame: The following 7 days after surgery]
- Pain during micturition [Time frame: The following 7 days after surgery]
- UTI [Time frame: The following 7 days after surgery]
- Urinary retention [Time frame: The following 7 days after surgery]
- Post-void residual volume [Time frame: The following 7 days after surgery]
Eligibility criteria
Inclusion criteria
- Adult women (≥18 years old).
- Undergoing benign vaginal gynecologic surgery with indwelling catheter during surgery.
- No bladder injury during surgery.
- Ability and willingness to consent.
- No known neurological or urinary conditions affecting voiding.
- No active urinary tract infection at time of catheter removal.
Exclusion criteria
- Bladder injury during surgery.
- Neurological disease affecting bladder function.
- Active urinary tract infection.
- Inability to void either standing in shower or sitting (depending on randomization).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Prevention
Study locations
Israel · 2 centers
- Assuta Ashdod Hospital — Ashdod
- Assuta Ashdod Medical Center — Ashdod
Identifiers
NCT: NCT07372547 · AAA-0147-25